Suez, Daniel <br/><br/>
Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America.  [electronic resource] 

 -  Journal of clinical immunology  10 2016 
 - 700-12 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-2592 
<br/><br/><label>Standard No.: </label>10.1007/s10875-016-0327-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Bacterial Infections--etiology<br/>Child<br/>Child, Preschool<br/>Female<br/>Humans<br/>Immunoglobulins, Intravenous--administration & dosage<br/>Immunologic Deficiency Syndromes--complications<br/>Infusions, Subcutaneous<br/>Male<br/>Middle Aged<br/>Quality of Life<br/>Treatment Outcome<br/>Young Adult